- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5513 - 1,4-Benzodiazepines, e.g. diazepam
Patent holdings for IPC class A61K 31/5513
Total number of patents in this class: 1466
10-year publication summary
|
105
|
113
|
112
|
168
|
137
|
133
|
154
|
136
|
98
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19517 |
36 |
| Bristol-myers Squibb Company | 4863 |
32 |
| Alkermes Pharma Ireland Limited | 288 |
27 |
| GW Research Limited | 342 |
21 |
| Enanta Pharmaceuticals, Inc. | 422 |
20 |
| Nippon Chemiphar Co., Ltd. | 236 |
20 |
| Ovid Therapeutics Inc | 163 |
17 |
| Boehringer Ingelheim International GmbH | 4754 |
16 |
| Jazz Pharmaceuticals Research UK Limited | 69 |
16 |
| Neurelis, Inc. | 49 |
14 |
| Pfizer Inc. | 3368 |
13 |
| Ayala Pharmaceuticals Inc. | 18 |
13 |
| The Johns Hopkins University | 5533 |
11 |
| io Therapeutics, Inc. | 118 |
11 |
| Clexio Biosciences Ltd. | 100 |
11 |
| Novartis AG | 11254 |
10 |
| F. Hoffmann-La Roche AG | 7942 |
10 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
10 |
| Aquestive Therapeutics, Inc. | 164 |
10 |
| Immunome Inc. | 47 |
9 |
| Other owners | 1139 |